Document Detail

Genetic polymorphisms that predict outcome and need for treatment in cardiovascular disease.
MedLine Citation:
PMID:  16943719     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF REVIEW: Interest in the genetic determinants of complications of cardiovascular disease, and the resultant influence on management, has increased. We have therefore reviewed the literature in the last 12-16 months for studies documenting genetic risk of complications. The focus is on risk of complications or differences in management, rather than only susceptibility to cardiovascular disease itself. RECENT FINDINGS: Polymorphisms in myocyte enhancer factor 2A, a transcription factor, tumor necrosis factor (ligand) superfamily, member 4, the OX40 ligand, and proprotein convertase subtilisin/kexin type 9, which affect low-density lipoprotein levels, have all been associated with an altered risk of coronary artery disease and myocardial infarction. A preliminary study of genotype-specific therapy of the 5-lipoxygenase pathway has shown benefit in the intermediate endpoint of reduction in inflammatory markers in patients at risk of myocardial infarction and stroke. Bleeding and renal complications after coronary artery bypass surgery have also been associated with genetic polymorphisms. A familial study confirms a genetic association with thoracic aortic aneurysms. SUMMARY: A familial risk of cardiovascular disease is well known. The specific genotypes at risk are increasingly being discovered. The science has progressed to the point that genotype-specific interventions are increasingly feasible.
Sachin Yende; Richard G Wunderink
Related Documents :
9489129 - Angiotensin i-converting enzyme insertion/deletion polymorphism: clinical implications.
15928029 - New definition of microalbuminuria in hypertensive subjects: association with incident ...
19177599 - Heartwatch: a secondary prevention programme in primary care in ireland.
11812069 - Association of the gpia c807t and gpiiia pla1/a2 polymorphisms with premature myocardia...
3893489 - Effect of smoking habits and timolol treatment on mortality and reinfarction in patient...
8073409 - Factor vii, antithrombin iii, leukocyte and platelet counts in a sample of black and wh...
6193699 - Morphology of ventricular premature beats as an aid in the electrocardiographic diagnos...
3954519 - Five-year follow-up of friedreich's ataxia cardiomyopathy.
541709 - Can the extent of coronary artery disease be predicted from thallium-201 myocardial ima...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in critical care     Volume:  12     ISSN:  1070-5295     ISO Abbreviation:  Curr Opin Crit Care     Publication Date:  2006 Oct 
Date Detail:
Created Date:  2006-08-31     Completed Date:  2007-01-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9504454     Medline TA:  Curr Opin Crit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  420-5     Citation Subset:  IM    
Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiovascular Diseases / complications*,  genetics*,  prevention & control,  surgery
Genetic Predisposition to Disease*
Polymorphism, Genetic*
Risk Assessment
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Biomarkers of outcome from cardiovascular disease.
Next Document:  Microcirculatory disorders in sepsis and transplantation: therapy with natural coagulatory inhibitor...